Exome sequencing in over 63,000 patients in TIMI trials uncovers pathogenic cardiomyopathy variant carriers with high risk for heart failure and cardiovascular death
Event:
ESC Congress 2024
Topic:
Epidemiology, Prognosis, Outcome
Session:
Probing deeper into the pathophysiology of heart failure